Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Debt Ratio (2023 - 2025)

Goldenwell Biotech's Debt Ratio history spans 3 years, with the latest figure at 0.5 for Q1 2025.

  • For Q1 2025, Debt Ratio changed N/A year-over-year to 0.5; the TTM value through Mar 2025 reached 0.5, changed N/A, while the annual FY2024 figure was 0.43, 28.66% up from the prior year.
  • Debt Ratio reached 0.5 in Q1 2025 per GWLL's latest filing, up from 0.43 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.5 in Q1 2025 to a low of 0.33 in Q4 2023.
  • Average Debt Ratio over 3 years is 0.42, with a median of 0.43 recorded in 2024.
  • The largest YoY upside for Debt Ratio was 28.66% in 2024 against a maximum downside of 28.66% in 2024.
  • A 3-year view of Debt Ratio shows it stood at 0.33 in 2023, then increased by 28.66% to 0.43 in 2024, then grew by 16.82% to 0.5 in 2025.
  • Per Business Quant, the three most recent readings for GWLL's Debt Ratio are 0.5 (Q1 2025), 0.43 (Q4 2024), and 0.33 (Q4 2023).